AAUM (Average Assets Under Management) of ₹23.63 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.8% | 80.7% | ▲ +0.9% |
| Healthcare Services | 20.0% | 19.3% | ▼ -0.8% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 80.7% | 81.2% | ▲ +0.5% |
| Healthcare Services | 19.3% | 18.9% | ▼ -0.4% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Gland Pharma Limited ₹50.91 L |
Pharmaceuticals & Biotechnology | 2.04% |
| 2 | Krishna Institute Of Medical Sciences Limited ₹43.89 L |
Healthcare Services | 1.76% |
| # | Stock | Sector | Last Weight (Aug 2026) |
|---|---|---|---|
| 1 | Piramal Pharma Limited ₹29.15 L |
Pharmaceuticals & Biotechnology | 1.15% |
| 2 | Syngene International Limited ₹16.65 L |
Healthcare Services | 0.66% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Dr. Reddy's Laboratories Limited ₹1.66 Cr |
Pharmaceuticals & Biotechnology | 6.05% | 6.65% | +0.60% |
| 2 | Laurus Labs Limited ₹1.70 Cr |
Pharmaceuticals & Biotechnology | 6.41% | 6.82% | +0.41% |
| 3 | Mankind Pharma Limited ₹62.52 L |
Pharmaceuticals & Biotechnology | 2.36% | 2.51% | +0.15% |
| 4 | Abbott India Limited ₹31.19 L |
Pharmaceuticals & Biotechnology | 1.15% | 1.25% | +0.10% |
| 5 | Divi's Laboratories Limited ₹2.60 Cr |
Pharmaceuticals & Biotechnology | 10.35% | 10.44% | +0.09% |
| 6 | Alkem Laboratories Limited ₹68.62 L |
Pharmaceuticals & Biotechnology | 2.68% | 2.75% | +0.07% |
| 7 | Zydus Lifesciences Limited ₹63.45 L |
Pharmaceuticals & Biotechnology | 2.50% | 2.55% | +0.05% |
| 8 | IPCA Laboratories Limited ₹58.99 L |
Pharmaceuticals & Biotechnology | 2.36% | 2.37% | +0.01% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited ₹4.24 Cr |
Pharmaceuticals & Biotechnology | 18.08% | 17.01% | -1.07% |
| 2 | Max Healthcare Institute Limited ₹1.52 Cr |
Healthcare Services | 6.67% | 6.12% | -0.55% |
| 3 | Fortis Healthcare Limited ₹88.41 L |
Healthcare Services | 4.07% | 3.55% | -0.52% |
| 4 | Apollo Hospitals Enterprise Limited ₹1.85 Cr |
Healthcare Services | 7.88% | 7.43% | -0.45% |
| 5 | Biocon Limited ₹56.87 L |
Pharmaceuticals & Biotechnology | 2.53% | 2.28% | -0.25% |
| 6 | Lupin Limited ₹1.09 Cr |
Pharmaceuticals & Biotechnology | 4.57% | 4.36% | -0.21% |
| 7 | Torrent Pharmaceuticals Limited ₹1.56 Cr |
Pharmaceuticals & Biotechnology | 6.39% | 6.25% | -0.14% |
| 8 | Cipla Limited ₹1.67 Cr |
Pharmaceuticals & Biotechnology | 6.82% | 6.70% | -0.12% |
| 9 | Glenmark Pharmaceuticals Limited ₹77.47 L |
Pharmaceuticals & Biotechnology | 3.21% | 3.11% | -0.10% |
20 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹4.24 Cr |
Pharmaceuticals & Biotechnology |
17.01%
|
|
| 2 |
₹2.60 Cr |
Pharmaceuticals & Biotechnology |
10.44%
|
|
| 3 |
₹1.85 Cr |
Healthcare Services |
7.43%
|
|
| 4 |
₹1.70 Cr |
Pharmaceuticals & Biotechnology |
6.82%
|
|
| 5 |
₹1.67 Cr |
Pharmaceuticals & Biotechnology |
6.70%
|
|
| 6 |
₹1.66 Cr |
Pharmaceuticals & Biotechnology |
6.65%
|
|
| 7 |
₹1.56 Cr |
Pharmaceuticals & Biotechnology |
6.25%
|
|
| 8 |
₹1.52 Cr |
Healthcare Services |
6.12%
|
|
| 9 |
₹1.09 Cr |
Pharmaceuticals & Biotechnology |
4.36%
|
|
| 10 |
₹1.02 Cr |
Pharmaceuticals & Biotechnology |
4.09%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.